Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
ENTITY
SMARTSCORE: 3.4/5
Soligenix (SNGX US)
Watchlist
9
Analysis
Health Care
•
United States
Soligenix, Inc. develops therapeutics and vaccines. The Company researches treatments for gastrointestinal Graft-versus-Host disease and cancer, and develops vaccines for military and civilian applications.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
08 Nov 2024 21:14
424B3 | Prospectus
Attachment
Exchange Announcement •
08 Nov 2024 21:12
424B3 | Prospectus
Attachment
Exchange Announcement •
08 Nov 2024 21:10
424B3 | Prospectus
Attachment
Exchange Announcement •
08 Nov 2024 21:06
Quarterly Report (Form 10-Q | Period ending 2024-09-30)
Attachment
Exchange Announcement •
11 Oct 2024 20:05
Current Report (Form 8-K | Period ending 2024-10-08)
Attachment
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3
x